Home » Stocks » AbbVie » News

AbbVie Inc. (ABBV)

Stock Price: $83.92 USD -0.42 (-0.50%)
Updated Oct 26, 2020 4:02 PM EDT - Market closed
After-hours: $84.00 +0.08 (0.10%) Oct 26, 7:56 PM
Zacks Investment Research - 7 hours ago

In the latest trading session, AbbVie (ABBV) closed at $83.92, marking a -0.5% move from the previous day.

Seeking Alpha - 15 hours ago

AbbVie is seeing success with new drugs. The company offers an attractive dividend yield and trades at a low valuation.

Zacks Investment Research - 18 hours ago

Investors will focus on any recovery in AbbVie's (ABBV) sales amid the coronavirus pandemic when it reports third-quarter results.

Seeking Alpha - 1 day ago

In October and July Kiplinger Today listed Analyst and Kiplinger favorite dividend stocks. Analyst October favorites numbered 25, plus 15 from Kiplinger, with one repeated left 39 total. These...

Other stocks mentioned: BKR, C, CFG, COP, CVX, DVN, EOG, EPD, FANG, MPC, PSX, VLO, WMB
Seeking Alpha - 2 days ago

Coronavirus cases around the globe are rising, especially in Europe. This could pressure global economies, as lockdowns are more likely. Some countries in Europe have already enacted such meas...

Other stocks mentioned: AFL, JNJ, MO, O, T, WBA
Seeking Alpha - 2 days ago

AbbVie, one of the highest-quality dividend aristocrats, has been falling steadily for weeks, for no fundamental reason. So let's take a look at the six reasons that 5.7% yielding AbbVie is po...

Zacks Investment Research - 3 days ago

AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 4 days ago

From May to July, Kiplinger Today listed five sets of dividend stocks sorted as favorites, super-safe, durable, centenarian, and MoPays. Those five 'outstanding dividend' articles revealed 56 ...

Other stocks mentioned: EPD, GAIN, IBM, LMT, LTC, MAIN, MET, MRK, O, PBCT, PRU, SJR, UNM, XOM
Zacks Investment Research - 5 days ago

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?

Zacks Investment Research - 6 days ago

In the latest trading session, AbbVie (ABBV) closed at $84.25, marking a -0.07% move from the previous day.

InvestorPlace - 6 days ago

If you're looking to generate income, here are 7 dividend stocks to buy that will deliver generous total returns over the long haul. The post 7 Dividend Stocks To Buy For Big Returns In Your B...

Other stocks mentioned: APO, BNS, INTC, MMM, SPG, TSCO
Zacks Investment Research - 6 days ago

AbbVie (ABBV) files regulatory applications with the FDA and the EMA, seeking approval for a new indication of Rinvoq ??? atopic dermatitis.

Seeking Alpha - 6 days ago

AbbVie: Now It's Time To Dollar-Cost-Average On This 5.6% Yield

The Motley Fool - 1 week ago

Already given the green light for rheumatoid arthritis, the drug could soon be prescribed for a common skin ailment.

PRNewsWire - 1 week ago

NORTH CHICAGO, Ill., Oct. 19, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications to the U.S. Food and Drug Administration (FDA) and European Medicines ...

Zacks Investment Research - 1 week ago

Roche (RHHBY) and partner AbbVie obtain full FDA approval for leukemia drug, Venclexta, in combination with Vidaza or Dacogen or low-dose cytarabine (LDAC).

Other stocks mentioned: RHHBY
PRNewsWire - 1 week ago

NORTH CHICAGO, Ill., Oct. 19, 2020 /PRNewswire/ -- ("AbbVie") announced today the commencement of its offers to exchange (the "Registered Exchange Offers") any and all of its outstanding (i) $...

The Motley Fool - 1 week ago

These are investments you won't have to worry about checking on every day.

Other stocks mentioned: V
PRNewsWire - 1 week ago

NORTH CHICAGO, Ill., Oct. 16, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in...

InvestorPlace - 1 week ago

Times have been tough lately for income investors, but these high-yield stocks whose dividends are safe remain worth a second look. The post 5 High-Yield Stocks for 5%-Plus Dividend Payouts ap...

Other stocks mentioned: ENB, IBM, PM, UNM
InvestorPlace - 1 week ago

While the coronavirus has brought excitement back to the markets, it’s the contrarian who is eyeballing value stocks that stands to win in the long run. The post 7 Value Stocks To Buy in an Ov...

Other stocks mentioned: ALNPY, KEP, MMM, MOMO, MRK, VRS
Seeking Alpha - 1 week ago

Buy AbbVie Before It Raises Dividends Again

24/7 Wall Street - 1 week ago

To say that hedge fund and mutual fund managers tend to follow the herd is an incredible understatement and always has been.

Other stocks mentioned: BMY, JNJ, MRK, UNH
The Motley Fool - 1 week ago

Both are large pharmaceutical companies, but these stocks have some huge differences that can help investors pick the better long-term investment.

Other stocks mentioned: JNJ
Zacks Investment Research - 1 week ago

AbbVie (ABBV) closed at $87.83 in the latest trading session, marking a -0.55% move from the prior day.

Market Watch - 1 week ago

Shares of AbbVie were down 0.1% in trading on Tuesday after the National Institutes of Health said it is running a mid-stage clinical trial evaluating a monoclonal antibody it developed with t...

Seeking Alpha - 2 weeks ago

Dividend Changes: October 3-9, 2020

Other stocks mentioned: AEE, AON, MCD, NWN, RPM, THO
Seeking Alpha - 2 weeks ago

"S&P 500 Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years." - us.spindices.com.

Other stocks mentioned: BEN, CAH, CVX, FRT, O, PBCT, T, WBA, XOM
Seeking Alpha - 2 weeks ago

The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into October of 2020.

Other stocks mentioned: ABC, AVB, CSCO, CVS, FRT, GD, INTC, O, PRU, RGA, SIEGY, SNA, SPG
PRNewsWire - 2 weeks ago

IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Der...

Seeking Alpha - 2 weeks ago

5 Dividend Stocks That Remain Good Buys In This Roller Coaster Market

Other stocks mentioned: EPD, GILD, INGR, UBA, UBP
Zacks Investment Research - 2 weeks ago

In the latest trading session, AbbVie (ABBV) closed at $87.07, marking a +1.37% move from the previous day.

GuruFocus - 2 weeks ago

Buying shares of companies trading well above off their average valuation and dividend yield can mean adding a stock with significant growth potential.

GuruFocus - 3 weeks ago

As of Oct. 2, the following stocks seem to be undervalued by the market, as their price-earnings ratios are below 20 and their price-earnings to growth (PEG) ratios stand below 1. Furthermore,...

Other stocks mentioned: BLDR, SBS
24/7 Wall Street - 3 weeks ago

While technology has been the engine that has driven stock market performance for some time now, increasingly we are seeing a seismic shift to health care among many portfolio managers, and wi...

Other stocks mentioned: BSX, MDT, SYK, ZBH
Business Wire - 3 weeks ago

LOS ANGELES--(BUSINESS WIRE)---- $ABBV #ABBV--ABBV LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against AbbVie Inc.

InvestorPlace - 3 weeks ago

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth. The post 7 Dividend Stocks Perfect for...

Other stocks mentioned: CVS, MMM, MO, OKE, T, TAK
Reuters - 3 weeks ago

A federal appeals court on Wednesday reversed an order that had required AbbVie Inc and a partner to disgorge $448 million in profit, in antitrust litigation brought by the U.S. Federal Trade ...

Zacks Investment Research - 3 weeks ago

AbbVie's (ABBV) elezanumab is presently being evaluated in a phase II study for spinal cord injury.

The Motley Fool - 4 weeks ago

These Dividend Aristocrats could help you to weather another coronavirus market storm.

Other stocks mentioned: T, WBA
The Motley Fool - 1 month ago

AbbVie could turn out to be a top-notch investment despite the upcoming expiration of its Humira patent.

The Motley Fool - 1 month ago

These big pharma companies are surviving the pandemic, and their solid dividends and consistent growth should help them do well in the next recession.

Other stocks mentioned: JNJ, LLY
Seeking Alpha - 1 month ago

4 Dividend Growth Opportunities To Benefit From Market Decline

Other stocks mentioned: LMT, MO, STOR
Seeking Alpha - 1 month ago

2020 is shaping up to be another record year for AbbVie.

Zacks Investment Research - 1 month ago

AbbVie (ABBV) closed the most recent trading day at $89.09, moving -1.13% from the previous trading session.

CNBC Television - 1 month ago

Video: Why this health care strategist likes the work-from-home trade

CNBC's Kelly Evans discusses the best work-from-home health care equity investments with Jared Holz of Jefferies Health Care Strategy.

Other stocks mentioned: ABT, MD
InvestorPlace - 1 month ago

The stock market may have forgotten about these seven undervalued stocks, but you can pick them up now on the cheap. The post 7 Undervalued Stocks With Massive Potential appeared first on In...

Other stocks mentioned: INTC, MU, STX, TEVA, WBA, WDC
Investors Business Daily - 1 month ago

AbbVie stock slipped when a House committee looking at drug prices said it would issue a subpoena, but the Allergan owner is working on coronavirus treatments. Is AbbVie stock a buy now?

The Motley Fool - 1 month ago

Generous dividends and long-term staying power make these two companies appealing to buy at a bargain.

Other stocks mentioned: GILD
The Motley Fool - 1 month ago

Most stocks are anything but cheap right now. These are three great exceptions.

Other stocks mentioned: BMY, CVS

Latest From StockTwits